Butea superba is a traditional tuberous Thai plant enriched with flavonoids that is used for treating erectile dysfunction. We investigated the mutagenic and antimutagenic potentials of a B. superba extract by using the pre-incubation method of the Ames test. Salmonella typhimurium strains TA 98 and TA 100 were applied as the tester strains in the presence and absence of an S9 mixture. Prior to the mutagenic and antimutagenic tests, the survival of the tester strains was measured by treating with the B. superba extract. The results show that the B. superba extract exhibited dose-dependent cytotoxic effects. Data from the Ames test revealed that the B. superba extract to be non-mutagenic in the presence and absence of the S9 mixture. In contrast, the B. superba extract showed antimutagenic potential towards either or both of the tested mutagens: 2-(2-furyl)-3-(5-nitro-2-furyl)-acrylamide (AF-2) and benzo(a)pyrene (B(a)P) in the respective presence and absence of the S9 mixture, respectively. The plant antimutagenic activity was confirmed by a rec assay. A further study by micronucleus test demonstrated that the B. superba extract at the maximum loading volume could induce acute micronucleus formation in the tested animals. The in vitro mutagenic and antimutagenic assays confirmed the safe consumption of B. superba products at low dose (not more than 781.25 g/ml of the plant extract), but the in vivo genotoxic assay demonstrated the unsafe consumption at a high dose (300 mg/kg of the BW plant extract or 16 g/kg of the BW plant powder).
Investigation of the mutagenic/antimutagenic effects of plants used as traditional medicines in developing countries are receiving great interest, with some proof of safety or low genotoxicity of the long-term consumption of the plant products. Screening of medicinal plants used in traditional South African medicine for genotoxic effects has resulted in few plant samples with such effects. [1] [2] [3] Some of the Mexican plants used in traditional medicine have exhibited mutagenic activity and/ or acute toxicity, 4) and some of the Chinese tea samples have exhibited antimutagenic activity. 5) Thai herbal plants have also been evaluated and resulted in finding an antimutagenic effect. 6, 7) Butea superba Roxb., of the family Leguminosae is an indigenous Thai herb with the domestic name of ''red kwao krua.'' The plant's large, elongated tubers have been used in traditional remedies for male rejuvenation purposes, especially for promoting potency. The plant which is found in the deciduous forests of Thailand, has received great interest as it was effective for treating erectile dysfunction in a clinical trial with Thai volunteers 8) by a comparable evaluation method to that for the worldwide clinical trial of Sildenafil. 9) The plant extract exhibited a vasodilatating effect on intracavernous pressure in male rats which is a positive result for penile erection. 10) B. superba inhibited the activity of acetylcholinesterase is one investigation for the treatment of Alzheimer's disease. 11) A rat chronic toxicity study of B. superba showed no adverse effect but it did promote rat sperm production. 12, 13) The plant exhibited an androgenic effect on female rats, 14) but androgen disruption in male rats. 15) B. superba powder and its crude extract has recently become very popular for oralconsumption in the form of a dietary supplement or traditional medicine as a male potency booster, and also for topical application as a product for treating erectile dysfunction. We therefore conducted this study to evaluate the mutagenic and genotoxic risk of the crude plant extract. The results of this study should directly benefit to those who need to develop products for human consumption from the plant powder, plant extract and food ingredients derived from B. superba.
Materials and Methods
Chemicals. The chemicals and solvents used throughout the experiments were of analytical grade. Benzo(a)pyrene (B(a)P) was supplied by Sigma Chemical Co. (St. Louis, MO, USA). Dimethysulfoxide (DMSO) and the Folin-Ciocalteu's phenol reagent were purchased from Merck (Darmstadt, Germany). 2-(2-Furyl)-3-(5-nitro-2-furyl)-acrylamide (AF-2) was purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan) and the tryptic soy broth, Bacto agar was purchased from Difco Laboratories (Detroit, Michigan, USA). Nutrient broth no. 2 was purchased from Oxoid, Ltd. (Basingstoke and Hants, England), ampicillin was purchased from General Drug House Co., Ltd. (Bangkok, Thailand) and cyclophosphamide was purchased from Asta Medica, Frankfurt, Germany.
Plant material. The plant material was collected and identified, and a herbarium voucher specimen was deposited, and extracted as previously described.
16) The plant ethanolic extract was dissolved in DMSO, adjusted to the concentration of 2.5 and 5 mg/plate, and y To whom correspondence should be addressed. Fax: +66-2-2185386; E-mail: cwichai@sc.chula.ac.th Biosci. Biotechnol. Biochem., 74 (5), [923] [924] [925] [926] [927] 2010 filtered through a 0.45-mm sterile membrane filter disc for the mutagenic and anti-mutagenic assays. The plant extract was dissolved in 0.7 ml of 1% EtOH for the micronucleus assay.
Standard mutagens. AF-2 and B(a)P were used as the mutagens. AF-2 was dissolved in DMSO at a concentration of 2 mg/ml for TA98 and 0.2 mg/ml for TA100 when tested in the absence of the S9 mixture. B(a)P was dissolved in DMSO at a concentration of 200 mg/ml for TA98 and at 100 mg/ml for TA100 when tested in the presence of the S9 mixture, CP was dissolved in 0.7 ml of 1% EtOH and intraperitoneally injected (i.p.) into the animals at a dose of 80 mg/kg of BW for the micronucleus assay.
Bacterial strains. Salmonella typhimurium strain TA 98 (his D3052, rfa, uvrB, pKM101) and strain TA100 (his G46, rfa, uvrB, pKM101) were provided by the Biochemistry and Chemical Carcinogenesis Section, Research Division, National Cancer Institute, Bangkok, Thailand. An inoculum (20 ml) of a thawed permanent culture was added to 20 ml of nutrient broth no. 2 for all the assays. Bacillus subtilis strains H17 and M45 were respectively recombinationproficient (rec þ ) and recombination-deficient (rec À ), and were stored frozen at the Department of Microbiology, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand. All the assays used an inoculum (20 ml) of a thawed permanent culture was added to 20 ml of tryptic soy broth. The bacterial cultures were incubated overnight at 37 C while shaking until an approximately concentration of 1:2 Â 10 9 bacteria/ml was obtained.
Metabolic activation system (S9 mixture). A rat liver S9 fraction induced by sodium phenobarbital and 5,6-benzoflavone in male Sprague-Dawley rats was prepared as previously described.
17)
Bacterial cytotoxicity test. Fifteen revertant colonies of S. typhimurium strain TA100 derived from the induction with AF-2 in the absence of the S9 mixture were cultured for 14 h in nutrient broth at 37 C in a shaken water bath. The turbidity was adjusted to be equivalent to Mcfarland 0.5 with phosphate buffer at pH 7.4. Fifty ml of the adjusted culture was mixed with 100 ml of the non-induced bacterial culture. The final culture was mixed with 500 ml of the phosphate buffer at pH 7.4 and 100 ml of the plant extract at a concentration of 2.5, 5, 10, or 20 mg/plate. The plant extract was replaced by the same amount of DMSO for a negative control. The viable cells were counted after incubation overnight. The dose exhibiting 50% lethality to the bacterial cells is designed as the IC 50 . Three consecutive concentrations and one dose of the plant extract were tested.
Evaluation of the mutagenicity/antimutagenicity by preincubation method.
Ames assay. The reversion assays were carried out on the sample solutions of various concentrations of the plant extracts with TA98 and TA100, with and without the S9 mixture.
18) The mixture, consisting of 0.1 ml of sample solution, 0.5 ml of the S9 mixture and 0.1 ml of the bacterial suspension, was pre-incubated for 20 min at 37 C while gently shaking. Molten soft agar (2.5 ml, containing 0.5 mM l-histidine and 0.5 mM d-biotin) was added, and the resulting mixture of 3.2 ml was poured onto the minimal glucose agar. The tested plates were incubated for 2 d at 37 C and the revertant colonies formed were scored. AF-2 and B(a)P were used as positive controls. The antimutagenicity of the plant extracts was evaluated by comparing with both positive and negative controls. The antimutagenic assays consisted of 0.05 ml of a sample solution mixed with 0.05 ml of the reference mutagen. 19) The antimutagenicity is classified as negative, weak, moderate or strong based on the percentage inhibition.
Rec-assay. The rec-assay was carried out with spores of B. subtilis strains H17 and M45. Spore-agar plates were prepared by mixing 10 ml of tryptic soy agar with 0.1 ml of the spore suspension (2 Â 10 7 spores/ml). The sterile cork borer of 8 mm diameter was used to pierce the solidified agar and obtain a hole, giving a total of 5 holes per plate. Each well was applied with 0.02 ml of DMSO and 0.02 ml of the sample solution at the concentration of 2.5 and 5 mg/well. The diameter of the inhibition zone around each well for the H17 and M45 spore plates were measured and compared after an overnight incubation. AF-2 was used as a positive control. 20) Micronucleus test. Three independent in vivo micronucleus tests were performed on male Wistar rats, using 6 rats per group, weighting 160-200 g and supplied by the National Animal Production Center, Mahidol University, Nakornpathom, Thailand. The rats were kept in a room with a 12-h photo period at a temperature of 25 AE 1 C and provided with animal feed and tap water. The rats were sacrificed at 24, 48, and 72 h, after the plant extract had been i.p.-administered at a dose of 300 mg/kg of BW (equivalent to 16 g/kg of BW plant powder) dissolved in 0.7 ml of 1% EtOH, with 80 mg/kg of BW of CP (i.p.) and 0.7 ml of 1% EtOH respectively used as positive and negative controls. 21, 22) The air-dried slides with rat bone marrow micronuclei were stained with May-Grunwald and Giemsa. A total of 2000 polychromatic erythrocytes (PCEs) were scored per animal for determining the micronucleated polychromatic erythrocytes (MnPCEs). A total cell count of 1,000 erythrocytes was scored per animal in the analysis of polychromatic erythrocyte/non-chromatic erythrocyte (PCEs/NCEs). The experimental protocol was approved by the Animal Ethical Committee in accordance with the university guideline for the care and use of laboratory animals.
Statistical analyses. Each result is expressed as the mean AE S.E.M. of three independent experiments. An unpaired Student's t-test was used for analyzing of the test results with p < 0:05 being considered significant. The SPSS version 10.0 statistical software program for the analyses.
Results
Prior to the mutagenicity and antimutagenicity tests, the B. superba extract was evaluated for any cytotoxic effect towards the indicator strains used for the tests. The results in Table 1 show that the plant extracts had dose-dependent cytotoxicity with more effect to TA98 than to TA100 regarding the dose used.
The results from the pre-incubation method for the Ames test shown in Table 2 revealed that the B. superba extract was non-mutagenic towards S. typhimurium in the absence of the S9 mixture. It showed 34:69 AE 2:42 revertant colonies at the highest tested dose of 5 mg/plate in comparison with 27:31 AE 4:10 revertant colonies for the DMSO negative control, and 505:66 AE 7:60 revertant colonies for the AF-2 positive control in TA98 and 108:60 AE 1:40 revertant colonies at the highest tested dose of 5 mg/plate in comparison with 136:02 AE 7:70 revertant colonies for the DMSO negative control, and 694:32 AE 8:80 revertant colonies for the AF-2 positive control in TA100. The presence of the S9 mixture initiated more frequent revertant colonies for the negative control, positive control and tested The solution comprised 2.5 ml top agar, 100 ml plant samples, 500 ml buffer and 100 ml bacterial cultures of 1000 CFU/ml (total volume of 3.2 ml).
Means not sharing a common superscript letter in the same column of each plant extracts are significantly different (p < 0:05) as determined by Duncan's multiple range test. Ã 1 mg/plate is equal to 312.5 mg/ml.
samples in both TA98 and TA100. A limited test dose of 5 mg/plate was used to avoid the killing effect as seen in the cytotoxic test which was observed with a higher dose of the plant extract.
In consideration of the antimutagenic potentials, the B. superba extract in the presence of AF-2 showed an antimutagenic effect at the negative level towards both tester strains in the absence of the S9 mixture. It produced 13:19 AE 4:93 revertant colonies at the highest tested dose of 5 mg/plate in comparison with 27:31 AE 4:10 revertant colonies for the DMSO negative control and 505:66 AE 7:60 revertant colonies for the AF-2 positive control in TA98, and 2:41 AE 0:40 revertant colonies at the highest tested dose of 5 mg/plate in comparison with 136:02 AE 7:70 revertant colonies for the DMSO negative control, and 694:32 AE 8:80 revertant colonies for the AF-2 positive control, in TA100. The presence of the S9 mixture initiated more frequent revertant colonies in both the negative and positive control, but not the tested samples which showed no developed revertant colonies in both TA98 and TA100 ( Table 2) .
The rec assay with B. subtilis var. H17 (rec þ ) and M45 (rec À ) for the plant samples, negative control and positive control. The mutagenic test with M45 showed the plant sample at a dose of 5 mg/plate exhibiting a greater clearance zone of 10:53 AE 1:47 mm (p < 0:05) than 8:00 AE 0:00 mm for the DMSO negative control, but less than 21:36 AE 1:90 mm for the AF-2 positive control. The antimutagenic test with H17 showed the B. superba extract exhibiting a greater clearance zone of 11:73 AE 1:88 mm (p < 0:05) at the concentration of 2.5 mg/plate than 8:00 AE 0:00 mm for the DMSO negative control, and AF-2 positive control. The antimutagenic test with M45 demonstrated the B. superba extract in the presence of AF-2 exhibiting no difference in clearance zone for the AF-2 positive control at 21:36 AE 3:08 mm versus 21:36 AE 1:90 mm with a dose of 2.5 mg/plate. Inhibition of the formation of a clearance zone was seen with the dose of 5 mg/plate at 12:06 AE 0:97 mm versus 21:36 AE 1:90 mm against the positive control (p < 0:05, Table 3 ). However, the two plant extract concentration in the presence of AF-2 showed a significantly larger clear zone than the negative control (p < 0:05).
The B. superba extract with the longest treatment period of 72 h exhibited a significantly (p < 0:05) higher number of MnPCEs/1000 PCEs (4:92 AE 0:72) than the negative control (2:31 AE 0:33), but significantly (p < 0:05) fewer MnPCEs/1000 PCEs than with the cyclophosphamide positive control (14:43 AE 1:16). This result was confirmed by the greater amount of PCEs/ NCEs only with the positive control (p < 0:05), and not the negative control (Table 4) .
Discussion
The B. superba extract showed a dose dependent cytotoxic effect towards S. typhimurium TA98 and TA100 which were the strains used in the Ames test with IC 50 values in the not strongly toxic range of 837.50 mg/ml for TA98 and <781:25 . mg/ml for TA100. There is therefore a possibility that the decrease in the number of the revertant colonies might have partly been due to the cytotoxic effects of the plant extracts. This prompted us to use only a low concentration of the B. superba extracts in the Ames and rec assays. Although the plant extract exhibited moderate cytotoxicity toward MCF-7 cells, 16) the toxicity of the plant for oral consumption is also considered to have been low in an animal test. 17) The results of the Ames test revealed the plant extracts not to have any detectable mutagenic activity towards the two indicator strains either with or without metabolic activation by preincubating with the S9 mixture as the number of revertant colonies occurring on the agar plate plant extract containing was less than twice the number of revertant colonies for the negative control (spontaneous mutation). The plant extract thus showed negative mutagenic activity in comparison with the negative control. In the presence of the S9 mixture, the numbers of revertant colonies induced by the B. superba extract was increased in parallel with the DMSO-negative control. This finding indicates that the metabolic products from the plant extract had no influence on its relative potential in consideration of the test method with a negative control. It exhibited 2:41 AE 0:40 revertant colonies at the highest tested dose of 5 mg/plate of the plant sample in the antimutagenic assay with TA100. The precaution normally taken with herbal consumption as a traditional medicine is the toxic effect from its metabolites. 23) The test have also indicated that in the presence of the S9 mixture, there was an increasing in the numbers of revertant colonies shown by the B. superba extract in comparison with the negative control which is not considered to be at the mutagenic level. This implies that metabolites from the plant extract could have been activated with the test systems. This effect has previously been observed in an incubation test of the S9 mixture with the five major isoflavonoids of puerarin, daidzin, genistin, daidzein and genistein in MCF-7 cells. 24) The results revealed that the B. superba extract did not exhibit a mutagenic effect when rec assay was used in the study. The antimutagenicity test by the rec assay also confirmed that the plant extract had antimutagenic potential. Both tests thus confirmed the antimutagenic effect of the B. superba extract.
An additional genotoxicity study of the tested plant extract was performed by the micronucleus assay. The result of the test was only demonstrated at a high dose of the B. superba extract of 300 mg/kg of BW for the plant extract which is equivalent to 16 g/kg of BW for the plant powder. The results show that the plant extract did influence the acute micronucleus formation. This genotoxicity study demonstrates that a high concentration of the B. superba extract could exhibit partially acute genotoxic.
B. superba used in the present study is rich in flavonoids and flavonoid glycosides with a potent inhibitory effect on cAMP phosphodiesterase. 25) The first and second group of chemicals have exhibited a cytotoxic effect. 26, 27) Indian B. superba bark has been reported to contain flavonol glycoside 28) and flavone glycoside 29) with anti-microbial activity. Medicarpin, 30) formononetin, 31) 7,4 0 -dimethoxyisoflavone, prunetin 32) and 7-hydroxy-6,4 0 -dimethoxyisoflavone have been isolated from the plant tubers. Formononetin exhibited an IC 50 value of 37.30 mg/ml in the test with KB (human epidermoid carcinoma) and 32.70 mg/ml in the test with BC (breast cancer) cells. Prunetin exhibited an IC 50 value of 71.10 mg/ml in the test with KB cells and 47.30 mg/ml in the test with BC cells. 33) Taking these data into account, it is reasonable to conclude that the cytotoxicity and the non-mutagenic and antimutagenic potentials of B. superba were concerned with the major flavonoid ingredients.
Global demands for flavonoid products have recently been increasing due to their health benefits. These raw materials are also used in a wide variety of cosmetics, dietary supplements and food ingredients. The combination of the knowledge from the long-term consumption of the tested plants and the results from the present study lend confidence to the consumption of the plant materials at a low not high concentration. 
